Average Co-Inventor Count = 6.37
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Protagonist Therapeutics, Inc. (25 from 32 patents)
2. Janssen Biotech, Inc. (3 from 410 patents)
3. Affymax, Inc. (1 from 23 patents)
4. Protaganist Therapeutics, Inc. (1 from 1 patent)
27 patents:
1. 12478617 - Lipidated peptide inhibitors of interleukin-23 receptor
2. 12269856 - Hepcidin analogues and uses thereof
3. 12234300 - Conjugated hepcidin mimetics
4. 12018057 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
5. 11884748 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
6. 11845808 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
7. 11840581 - α4β7 thioether peptide dimer antagonists
8. 11807674 - Hepcidin analogues and uses thereof
9. 11753443 - Conjugated hepcidin mimetics
10. 11472842 - Analogues of hepcidin mimetics with improved in vivo half lives
11. 11041000 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
12. 10941183 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
13. 10787490 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
14. 10729676 - Opioid agonist peptides and uses thereof
15. 10626146 - α4β7 thioether peptide dimer antagonists